Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Abbott Laboratories (ABT)

NYSE: Health Care

Get a 5-page Ratings Report on (ABT) now
$37.76 0.28 | 0.75%
Today's Range: 37.11 - 37.84
ABT Avg. Daily Volume: 7,354,000
05/24/13 - 4:04 PM ET
  • Latest Dividend: 0.14
  • Latest Dividend Yield: 1.48%
  • Dividend Ex-Date: 04/11/13
  • Price Earnings Ratio: 9.82
  • Price Earnings Comparisons:
    ABT Sector Avg. S&P 500
    9.82 11.50 17.70
  • Price Performance History
    (% change):
    3 Mo 1 Yr 3 Yr
    9.18% 20.92% 60.72%
  • GROWTH 12 Mo 3 Yr CAGR
    Revenue 2.60 0.30 0.09
    Net Income 0.00 0.04 0.01
    EPS 23.60 0.01 0.00
  • Earnings for ABT:
    EBITDA 11.16B
    REVENUE 39.87B
Average Earnings Estimates
Qtr (06/13) Qtr (09/13) FY (12/13) FY (12/14)
Average Estimate $0.44 $0.53 $2.02 $2.27
Number of Analysts 13 12 18 17
High Estimate $0.45 $0.56 $2.08 $2.54
Low Estimate $0.43 $0.48 $1.99 $2.16
Prior Year $1.23 $1.30 $5.07 $2.02
Growth Rate (Year over Year) -64.23% -59.10% -60.19% 12.29%
(ABT) News

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 15,303.10 8.60 0.06%
NASDAQ 3,459.14 -0.28 -0.01%
S&P 500 1,649.60 -0.91 -0.06%
US 10 Yr 2.011% -0.012

Brokerage Partners

Advertising Partners

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.

Top Rated Stocks Top Rated Funds Top Rated ETFs